Crossref
journal-article
Springer Science and Business Media LLC
Nature (297)
References
30
Referenced
528
-
Vogelstein, B., Lane, D. & Levine, A. J. Surfing the p53 network. Nature 408, 307–310 (2000)
(
10.1038/35042675
) / Nature by B Vogelstein (2000) -
Vousden, K. H. & Lu, X. Live or let die: the cell's response to p53. Nature Rev. Cancer 2, 594–604 (2002)
(
10.1038/nrc864
) / Nature Rev. Cancer by KH Vousden (2002) -
Lane, D. How cells choose to die. Nature 414, 25–27 (2001)
(
10.1038/35102132
) / Nature by D Lane (2001) -
Grandori, C., Cowley, S. M., James, L. P. & Eisenman, R. N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653–699 (2000)
(
10.1146/annurev.cellbio.16.1.653
) / Annu. Rev. Cell Dev. Biol. by C Grandori (2000) -
Alexandrow, M. G., Kawabata, M., Aakre, M. & Moses, H. L. Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1. Proc. Natl Acad. Sci. USA 92, 3239–3243 (1995)
(
10.1073/pnas.92.8.3239
) / Proc. Natl Acad. Sci. USA by MG Alexandrow (1995) - Mitchell, K. O. & El-Deiry, W. S. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ. 10, 223–230 (1999) / Cell Growth Differ. by KO Mitchell (1999)
-
Claassen, G. F. & Hann, S. R. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor-β-induced cell-cycle arrest. Proc. Natl Acad. Sci. USA 97, 9498–9503 (2000)
(
10.1073/pnas.150006697
) / Proc. Natl Acad. Sci. USA by GF Claassen (2000) -
Warner, B. J., Blain, S. W., Seoane, J. & Massague, J. Myc downregulation by transforming growth factor β required for activation of the p15Ink4B G1 arrest pathway. Mol. Cell. Biol. 19, 5913–5922 (1999)
(
10.1128/MCB.19.9.5913
) / Mol. Cell. Biol. by BJ Warner (1999) -
Datto, M. B., Yu, Y. & Wang, X.-F. Functional analysis of the transforming growth factor β responsive elements in WAF1/Cip1/p21 promoter. J. Biol. Chem. 270, 28623–28628 (1995)
(
10.1074/jbc.270.48.28623
) / J. Biol. Chem. by MB Datto (1995) -
El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumour suppression. Cell 75, 817–825 (1993)
(
10.1016/0092-8674(93)90500-P
) / Cell by WS El-Deiry (1993) - Zeng, Y. X. & el-Deiry, W. S. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12, 1557–1564 (1996) / Oncogene by YX Zeng (1996)
-
Massague, J., Blain, S. W. & Lo, R. S. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 103, 295–309 (2000)
(
10.1016/S0092-8674(00)00121-5
) / Cell by J Massague (2000) -
Zeng, Y. X., Somasundaram, K. & el-Deiry, W. S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nature Genet. 15, 78–82 (1997)
(
10.1038/ng0197-78
) / Nature Genet. by YX Zeng (1997) -
Biggs, J. R., Kudlow, J. E. & Kraft, A. S. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271, 901–906 (1996)
(
10.1074/jbc.271.2.901
) / J. Biol. Chem. by JR Biggs (1996) - Waldman, T., Kinzler, K. W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995) / Cancer Res. by T Waldman (1995)
-
Bunz, F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497–1501 (1998)
(
10.1126/science.282.5393.1497
) / Science by F Bunz (1998) -
Gewirtz, D. A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57, 727–741 (1999)
(
10.1016/S0006-2952(98)00307-4
) / Biochem. Pharmacol. by DA Gewirtz (1999) -
Resnick-Silverman, L., St Clair, S., Maurer, M., Zhao, K. & Manfredi, J. J. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumour suppressor protein p53. Genes Dev. 12, 2102–2107 (1998)
(
10.1101/gad.12.14.2102
) / Genes Dev. by L Resnick-Silverman (1998) -
Zawel, L. et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611–617 (1998)
(
10.1016/S1097-2765(00)80061-1
) / Mol. Cell by L Zawel (1998) -
Staller, P. et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nature Cell Biol. 3, 392–399 (2001)
(
10.1038/35070076
) / Nature Cell Biol. by P Staller (2001) -
Seoane, J. et al. TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nature Cell Biol. 3, 400–408 (2001)
(
10.1038/35070086
) / Nature Cell Biol. by J Seoane (2001) -
Ziegelbauer, J. et al. Transcription factor MIZ-1 is regulated via microtubule association. Mol. Cell 8, 339–349 (2001)
(
10.1016/S1097-2765(01)00313-6
) / Mol. Cell by J Ziegelbauer (2001) -
Zindy, F. et al. Myc signaling via the ARF tumour suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424–2433 (1998)
(
10.1101/gad.12.15.2424
) / Genes Dev. by F Zindy (1998) -
Burri, N. et al. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab. Invest. 81, 217–229 (2001)
(
10.1038/labinvest.3780230
) / Lab. Invest. by N Burri (2001) -
Polyak, K., Waldman, T., He, T. C., Kinzler, K. W. & Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945–1952 (1996)
(
10.1101/gad.10.15.1945
) / Genes Dev. by K Polyak (1996) -
Reynisdottir, I., Polyak, K., Iavarone, A. & Massague, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9, 1831–1845 (1995)
(
10.1101/gad.9.15.1831
) / Genes Dev. by I Reynisdottir (1995) -
Peukert, K. et al. An alternative pathway for gene regulation by Myc. EMBO J. 16, 5672–5686 (1997)
(
10.1093/emboj/16.18.5672
) / EMBO J. by K Peukert (1997) -
Li, J. M., Nichols, M. A., Chandrasekharan, S., Xiong, Y. & Wang, X. F. Transforming growth factor beta activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270, 26750–26753 (1995)
(
10.1074/jbc.270.45.26750
) / J. Biol. Chem. by JM Li (1995) -
Hata, A. et al. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100, 229–240 (2000)
(
10.1016/S0092-8674(00)81561-5
) / Cell by A Hata (2000) -
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A. & Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843–852 (2000)
(
10.1016/S0092-8674(00)00188-4
) / Cell by Y Shang (2000)
Dates
Type | When |
---|---|
Created | 22 years, 10 months ago (Oct. 16, 2002, 3:12 p.m.) |
Deposited | 2 years, 3 months ago (May 18, 2023, 2:10 p.m.) |
Indexed | 1 month ago (July 26, 2025, 5:07 a.m.) |
Issued | 22 years, 10 months ago (Oct. 1, 2002) |
Published | 22 years, 10 months ago (Oct. 1, 2002) |
Published Online | 22 years, 10 months ago (Oct. 2, 2002) |
Published Print | 22 years, 10 months ago (Oct. 1, 2002) |
@article{Seoane_2002, title={Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage}, volume={419}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/nature01119}, DOI={10.1038/nature01119}, number={6908}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Seoane, Joan and Le, Hong-Van and Massagué, Joan}, year={2002}, month=oct, pages={729–734} }